THIS MORNING BULGARIA BECAME THE 8th EUROPEAN COUNTRY TO SUSPEND AZ COVID VACCINE. MEANWHILE THE TAOISEACH REQUESTS MEETING WITH AZ CEO TO SEEK A BOOST IN SUPPLY.
This morning Bulgaria temporary halted inoculations with the AstraZeneca Covid-19 vaccine until the European medicine regulator produces a written statement dispelling all doubts about the vaccine’s safety.(1)
“Until all doubts are dispelled and as long as the experts do not give guarantees that it does not pose a risk to the people, we are halting the inoculations with this vaccine,” prime minister Boyko Borissov said in a statement.
Yesterday Denmark temporarily halted use of the Oxford-AstraZeneca vaccine yesterday as a precaution, after reports of a number of blood clots and one death.(2)
Austria, Iceland, Estonia, Lithuania, Luxembourg and Latvia has already stopped using the vaccine while Austria investigates the death of two people and blot clot related illness among people who had the shot. (3)
Meanwhile Professor Karina Butler chair of the National Immunization Advisory Committee (NIAC) RTÉ radio’s Today with Claire Byrne show that the risk of clotting could be down to other reasons.(4)
When asked about patients refusing the AstraZeneca vaccine, Prof Butler said such refusals were based on a lack of understanding.
Denmark suspends AstraZeneca vaccine for two weeks after blood clot reports
Denmark suspends AstraZeneca vaccine for two weeks…
There would not be a choice and she encouraged patients to take whatever vaccine they were offered.
“All vaccines have proven to be extremely effective,” she said.
The effectiveness rates of AstraZeneca were no different from the mRNA vaccines of Pfizer and Moderna, she said.
The longer time between doses of AstraZeneca was an advantage as it gave the opportunity for more people to be vaccinated, Prof Butler added.
On the same show the director general of the HSE Paul Reid said the Taoiseach is seeking a meeting with the chief executive of AstraZeneca to discuss the production and supply of Covid-19 vaccines.(5)